Figure 1. Prenatal exposure to polyriboinosinic-polyribocytidylic acid (poly-I:C) during the early/middle gestational period (gestational day 9 - GD9) generates phenotypes related to positive symptoms. The exposure on GD17 (late gestational period) is related to the occurrence of behavioral correlates of negative/cognitive symptoms of the disorder.
